Page last updated: 2024-09-05

aezs 124 and phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2

aezs 124 has been researched along with phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 in 2 studies

Compound Research Comparison

Studies
(aezs 124)
Trials
(aezs 124)
Recent Studies (post-2010)
(aezs 124)
Studies
(phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2)
Trials
(phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2)
Recent Studies (post-2010) (phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2)
10021701

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Comaru-Schally, AM; Halmos, G; Irimpen, A; Nagy, A; Schally, AV1
Halmos, G; Rick, FG; Schally, AV; Seitz, S; Szalontay, L; Szepeshazi, K; Treszl, A1

Other Studies

2 other study(ies) available for aezs 124 and phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2

ArticleYear
Absence of binding of targeted analogs of somatostatin carrying cytotoxic radicals or radionuclides to growth hormone secretagogue receptors on human myocardium.
    Life sciences, 2003, Apr-25, Volume: 72, Issue:23

    Topics: 2-Hydroxyphenethylamine; Aged; Aniline Compounds; Doxorubicin; Humans; Indium Radioisotopes; Male; Middle Aged; Myocardium; Octreotide; Pyrroles; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Ghrelin; Somatostatin

2003
Inhibition of human non-small cell lung cancers with a targeted cytotoxic somatostatin analog, AN-162.
    Peptides, 2009, Volume: 30, Issue:9

    Topics: 2-Hydroxyphenethylamine; Aniline Compounds; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Binding, Competitive; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Membrane; Cell Survival; Down-Regulation; Doxorubicin; Drug Carriers; Gene Expression; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Octreotide; Receptors, Somatotropin; Somatostatin; Up-Regulation; Xenograft Model Antitumor Assays

2009